Citation Impact
Citing Papers
Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission
2004
Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi
2006
Leishmaniasis
2018 Standout
Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
2009
Neglected tropical diseases
2009 Standout
Diagnosis of canine visceral leishmaniasis: Biotechnological advances
2006
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Can fleas from dogs infected with canine visceral leishmaniasis transfer the infection to other mammals?
2007
Natural products: An evolving role in future drug discovery
2011 Standout
Participation of Rhipicephalus sanguineus (Acari: Ixodidae) in the epidemiology of canine visceral leishmaniasis
2004
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial
2007
Infectious Diseases of Dogs and Cats on Isabela Island, Galapagos
2008
Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil
2008
Immunomodulatory and antiparasitic effects of garlic–arteether combination via nitric oxide pathway in Plasmodium berghei-infected mice
2019
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Leishmaniavaccines: progress and problems
2006
Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells
2000
Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
2003
Cutaneous leishmaniasis
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part two
2008
IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis
2003
Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment
2002
Persistence ofLeishmaniaParasites in Scars after Clinical Cure of American Cutaneous Leishmaniasis: Is There a Sterile Cure?
2004
Infectiousness in a Cohort of Brazilian Dogs: Why Culling Fails to Control Visceral Leishmaniasis in Areas of High Transmission
2002
Canine leishmaniasis: epidemiological risk and the experimental model
2002
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Transmission of Leishmania infantum via blood transfusion in dogs: Potential for infection and importance of clinical factors
2006
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
2003
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)
2002
Leishmune® vaccine blocks the transmission of canine visceral leishmaniasis
2005
A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs
2007
A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S�o Gon�alo do Amaranto, RN)
2000
Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil?
2003
Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis
2007
Diagnosis of cutaneous leishmaniasis
2003
The FML-vaccine (Leishmune®) against canine visceral leishmaniasis: A transmission blocking vaccine
2005
Leishmaniasis
1999 Standout
Leishmune® vaccine: The newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine
2006
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine
2007
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Indications of the Protective Role of Natural Killer Cells in Human Cutaneous Leishmaniasis in an Area of Endemicity
1998
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Advances in leishmaniasis
2005 Standout
Characterization and speculations on the urbanization of visceral leishmaniasis in Brazil
2008 Standout
Epidemiology and Control of Neosporosis andNeospora caninum
2007 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Role of the Domestic Chicken (Gallus gallus)in the Epidemiology of Urban Visceral Leishmaniasis in Brazil
2002
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes
2004
Leishmaniasis: Current Status of Vaccine Development
2001
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
2008
Reflexões sobre a qualidade do diagnóstico da leishmaniose visceral canina em inquéritos epidemiológicos: o caso da epidemia de Belo Horizonte, Minas Gerais, Brasil, 1993-1997
2004
Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control
2006 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Works of O Genaro being referenced
Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil.
2001
Simple form of clinical sample preservation and Leishmania DNA extraction from human lesions for diagnosis of American cutaneous leishmaniasis via polymerase chain reaction.
2001
Relationship between Canine Visceral Leishmaniosis and the Leishmania (Leishmania) chagasi Burden in Dermal Inflammatory Foci
2006
Ocorrência de calazar em área urbana da grande Belo Horizonte, MG
1990
Characterization of Human T Lymphocyte-Mediated Immune Responses Induced by a Vaccine against American Tegumentary Leishmaniasis
1995
The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil.
1999
Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi
2006
Histopathology of human American cutaneous leishmaniasis before and after treatment
1998
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment
2001